Advanced search

Serotonin reuptake inhibitors selectively decrease proliferation and viability of activated T-cells

Veerle Gobin (UGent) , Katleen Van Steendam (UGent) and Dieter Deforce (UGent)
(2011) IMMUNOLOGY. 135(suppl. 1). p.183-183
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Gobin, Veerle, Katleen Van Steendam, and Dieter Deforce. 2011. “Serotonin Reuptake Inhibitors Selectively Decrease Proliferation and Viability of Activated T-cells.” In Immunology, 135:183–183.
APA
Gobin, V., Van Steendam, K., & Deforce, D. (2011). Serotonin reuptake inhibitors selectively decrease proliferation and viability of activated T-cells. IMMUNOLOGY (Vol. 135, pp. 183–183). Presented at the Annual congress of the British Society for Immunology.
Vancouver
1.
Gobin V, Van Steendam K, Deforce D. Serotonin reuptake inhibitors selectively decrease proliferation and viability of activated T-cells. IMMUNOLOGY. 2011. p. 183–183.
MLA
Gobin, Veerle, Katleen Van Steendam, and Dieter Deforce. “Serotonin Reuptake Inhibitors Selectively Decrease Proliferation and Viability of Activated T-cells.” Immunology. Vol. 135. 2011. 183–183. Print.
@inproceedings{2941953,
  author       = {Gobin, Veerle and Van Steendam, Katleen and Deforce, Dieter},
  booktitle    = {IMMUNOLOGY},
  issn         = {0019-2805},
  language     = {eng},
  location     = {Liverpool, UK},
  number       = {suppl. 1},
  pages        = {183--183},
  title        = {Serotonin reuptake inhibitors selectively decrease proliferation and viability of activated T-cells},
  volume       = {135},
  year         = {2011},
}

Web of Science
Times cited: